Northern Trust Corp Black Diamond Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 345,114 shares of BDTX stock, worth $766,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares

345,114

Previous 124,154 177.97%

Holding current value

$766,153

Previous $578,000 159.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.2 - $6.58 $928,032 - $1.45 Million	220,960 Added 177.97%	345,114 $1.5 Million
Q2 2024 Aug 14, 2024	BUY	$4.65 - $7.39 $93,567 - $148,701	20,122 Added 19.34%	124,154 $578,000
Q1 2024 May 14, 2024	SELL	$2.67 - $5.74 $15,104 - $32,471	-5,657 Reduced 5.16%	104,032 $527,000
Q4 2023 Feb 13, 2024	BUY	$1.77 - $3.03 $71,276 - $122,015	40,269 Added 58.01%	109,689 $308,000
Q3 2023 Nov 13, 2023	BUY	$2.87 - $4.99 $90,488 - $157,329	31,529 Added 83.21%	69,420 $199,000
Q2 2023 Aug 11, 2023	SELL	$1.43 - $6.18 $131 - $568	-92 Reduced 0.24%	37,891 $191,000
Q3 2022 Nov 14, 2022	BUY	$1.68 - $4.01 $243 - $581	145 Added 0.38%	37,983 $64,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.63 $228,162 - $552,152	-152,108 Reduced 80.08%	37,838 $93,000
Q1 2022 May 13, 2022	SELL	$2.66 - $5.61 $30,613 - $64,565	-11,509 Reduced 5.71%	189,946 $527,000
Q4 2021 Feb 08, 2022	SELL	$5.18 - $8.48 $10,354 - $16,951	-1,999 Reduced 0.98%	201,455 $1.07 Million
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $57,807 - $84,865	-6,833 Reduced 3.25%	203,454 $1.72 Million
Q2 2021 Aug 13, 2021	BUY	$12.19 - $28.17 $201,659 - $466,016	16,543 Added 8.54%	210,287 $2.56 Million
Q1 2021 May 12, 2021	SELL	$22.23 - $34.75 $228,435 - $357,091	-10,276 Reduced 5.04%	193,744 $4.7 Million
Q4 2020 Feb 11, 2021	SELL	$29.47 - $35.0 $50,776 - $60,305	-1,723 Reduced 0.84%	204,020 $6.54 Million
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $1.95 Million - $3.2 Million	74,398 Added 56.64%	205,743 $6.22 Million
Q2 2020 Aug 14, 2020	BUY	$22.3 - $44.8 $197,109 - $395,987	8,839 Added 7.22%	131,345 $5.54 Million
Q1 2020 May 14, 2020	BUY	$18.18 - $39.48 $2.23 Million - $4.84 Million	122,506 New	122,506 $3.06 Million

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $80.7M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Black Diamond Therapeutics, Inc. Transaction History